All In MedTech

FDA Clearance Tracker · P010030-S086

WEARABLE CARDIOVERTER DEFIBRILLATOR (WCD) 3000, 3100, 4000.

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Apr 25, 2017 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Apr 25, 2017

Approved

Time to decision

180 days

Received Oct 27, 2016. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P010030-S086
Device name
WEARABLE CARDIOVERTER DEFIBRILLATOR (WCD) 3000, 3100, 4000.
Applicant location
Pittsburgh, PA
Received
Oct 27, 2016
Decided
Apr 25, 2017
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Labeling Change - PAS
Original approval
P010030

Device type

Device class
Class III

Every decision under product code MVK

FDA's approval statement

As written in FDA's record.

Approval to modify the Zoll Wearable Cardioverter Defibrillator (WCD) 3000, 3100, and 4000 Operators Manuals to reflect the results of the Post-Approval Study.

Source documents

Other decisions for Zoll Manufacturing Corporation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

1 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.